Source: Annual Congress 2010 - From rare towards common lung diseases: diagnostic and monitoring challenges
Disease area: Respiratory infections



Rating:

Share or cite this content

Citations should be made in the following way:
N. Voskresenska, J. Voicehovska, G. Orlikov (Riga, Latvia). Exhaled nitric oxide (NO) – Proposed diagnostic criteria for pneumonias of various origins. Eur Respir J 2010; 36: Suppl. 54, 4621

Member's Comments

No comment yet.

Related content which might interest you: Comparison of exhaled nitric oxide values measured by two offline methods or NO breath Source: Annual Congress 2013 –Systemic and airway biomarkers in respiratory diseases Year: 2013 Exhaled nitric oxide reference values in healthy Tunisian adults Source: Annual Congress 2013 –Various issues in clinical respiratory physiology Year: 2013 Diagnosing asthma using exhaled nitric oxide (eNO) measurements Source: Annual Congress 2003 - Recognition, management and assessment of asthma including severe asthma Year: 2003 Measurement of exhaled nitric oxide in patients with pulmonary tuberculosis Source: Annual Congress 2013 –Diagnostic features of tuberculosis I Year: 2013 Exhaled nitric oxide (NO) in patients with chronic cough Source: Eur Respir J 2004; 24: Suppl. 48, 580s Year: 2004 Dynamics of the nitric oxide metabolites in the exhaled breath condensate (EBC) in atopic asthma (BA) children receiving various treatment options Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules Year: 2013 Exhaled NO (FENO50) in COPD - Results from the TIE-study Source: International Congress 2016 – Inflammatory biomarkers in airway diseases Year: 2016 Domiciliary diurnal variation of fractional exhaled nitric oxide (FeNO) to monitor asthma control Source: Annual Congress 2013 –Diagnosis and management of respiratory diseases Year: 2013 Fractional exhaled nitric oxide (FeNO) for an early diagnosis of asthma Source: Eur Respir J 2006; 28: Suppl. 50, 677s Year: 2006 Assessment of exhaled breath condensate contamination during measurement of nitric oxide metabolites Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Diagnostic use of exhaled nitric oxide (eNO) after lung transplantation Source: Eur Respir J 2006; 28: Suppl. 50, 723s Year: 2006 Utility of fractional exhaled nitric oxide (FeNO) in assessing asthma control following inhaled corticosteroid treatment Source: International Congress 2016 – Assessing lower airway inflammation with different tools Year: 2016 Exhaled nitric oxide in asthma Source: Eur Respir Monogr 2010; 49: 32-44 Year: 2010 Exhaled nitric oxide (NO) detection for monitoring airway inflammation in non-severe CAP Source: Annual Congress 2008 - Diagnostic tests in lower respiratory tract infections Year: 2008 Exhaled and nasal nitric oxide measurements: recommendations Source: Guideline 1997 Year: 1997 Exhaled nitric oxide (eNO) for an epidemiological study in adults Source: Eur Respir J 2005; 26: Suppl. 49, 281s Year: 2005 An increase in exhaled nitric oxide is not associated with activity in pulmonary sarcoidosis Source: Eur Respir J 2004; 24 : 609-614 Year: 2004 The experience of monitoring the exhaled nitric oxide (FeNO) during the anti-IgE-therapy (omalizumab) in children with uncontrolled severe asthma Source: International Congress 2015 – Exhaled biomarkers in monitoring airways disease Year: 2015 Increased exhaled nitric oxide levels predict uncontrolled asthma in children – Results from the MIDAS-study Source: Annual Congress 2012 - Exhaled biomarkers to assess airway inflammation Year: 2012